Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2001-06-01 (24 years)Status: ActiveBusiness sector: Fabrication de matériel médico-chirurgical et dentaireLocation: LYON (69009), Rhone
LABORATOIRE NUGUES : revenue, balance sheet and financial ratios
LABORATOIRE NUGUES is a French company
founded 24 years ago,
specialized in the sector Fabrication de matériel médico-chirurgical et dentaire.
Based in LYON (69009),
this company of category PME
shows in 2025 a revenue of 1.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LABORATOIRE NUGUES (SIREN 438128621)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
1 220 426 €
1 239 408 €
1 211 287 €
N/C
1 628 493 €
1 144 916 €
N/C
N/C
967 057 €
Net income
72 375 €
67 174 €
168 958 €
83 356 €
337 974 €
131 201 €
246 097 €
223 554 €
113 855 €
EBITDA
113 410 €
157 235 €
268 356 €
N/C
462 807 €
187 995 €
N/C
N/C
168 189 €
Net margin
5.9%
5.4%
13.9%
N/C
20.8%
11.5%
N/C
N/C
11.8%
Revenue and income statement
In 2025, LABORATOIRE NUGUES achieves revenue of 1.2 M€. Revenue is growing positively over 9 years (CAGR: +3.0%). Slight decline of -2% vs 2024. After deducting consumption (190 k€), gross margin stands at 1.0 M€, i.e. a rate of 84%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 113 k€, representing 9.3% of revenue. Warning negative scissor effect: despite revenue change (-2%), EBITDA varies by -28%, reducing margin by 3.4 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 72 k€, i.e. 5.9% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2025)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
1 220 426 €
Gross margin (2025)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
1 030 898 €
EBITDA (2025)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
113 410 €
EBIT (2025)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
98 808 €
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
72 375 €
EBITDA margin (2025)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
9.3%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 91%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.2 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 6.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
91.105%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
43.142%
Cash flow / Revenue (2025)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
6.854%
Repayment capacity (2025)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
3.156
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
3.642
17.217
19.517
11.21
12.616
50.192
92.596
81.541
91.105
Financial autonomy
73.958
73.821
68.482
73.677
78.127
47.765
45.292
45.374
43.142
Repayment capacity
0.124
None
None
0.348
0.291
None
1.813
2.571
3.156
Cash flow / Revenue
13.339%
None%
None%
13.767%
22.06%
None%
16.033%
7.609%
6.854%
Sector positioning
Debt ratio
91.112025
2023
2024
2025
Q1: 5.49
Med: 17.07
Q3: 41.92
Watch
In 2025, the debt ratio of LABORATOIRE NUGUES (91.11) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
43.14%2025
2023
2024
2025
Q1: 36.67%
Med: 56.53%
Q3: 69.09%
Average-15 pts over 3 years
In 2025, the financial autonomy of LABORATOIRE NUGUES (43.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
3.16 years2025
2023
2024
2025
Q1: 0.0 years
Med: 0.66 years
Q3: 1.52 years
Watch
In 2025, the repayment capacity of LABORATOIRE NUGUES (3.16) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 291.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 11.6x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
291.642
Interest coverage (2025)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
11.573
Liquidity indicators evolution LABORATOIRE NUGUES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
287.055
542.333
388.008
356.522
648.411
215.954
490.455
305.271
291.642
Interest coverage
0.041
None
None
0.341
0.0
None
3.394
9.727
11.573
Sector positioning
Liquidity ratio
291.642025
2023
2024
2025
Q1: 181.98
Med: 251.18
Q3: 365.98
Good-16 pts over 3 years
In 2025, the liquidity ratio of LABORATOIRE NUGUES (291.64) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
11.57x2025
2023
2024
2025
Q1: 0.0x
Med: 0.83x
Q3: 3.14x
Excellent+18 pts over 3 years
In 2025, the interest coverage of LABORATOIRE NUGUES (11.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 43 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 23 days. The company must finance 20 days of gap between collections and payments. Inventory turnover is 28 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 63 days of revenue, i.e. 212 k€ to permanently finance. Over 2017-2025, WCR increased by +112%, requiring additional financing.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
212 330 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
43 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
23 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
28 j
WCR in days of revenue (2025)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
63 j
WCR and payment terms evolution LABORATOIRE NUGUES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
100 245 €
0 €
0 €
168 108 €
304 740 €
0 €
274 550 €
265 035 €
212 330 €
Inventory turnover (days)
16
0
0
20
20
0
43
36
28
Customer payment term (days)
36
0
0
45
39
0
46
50
43
Supplier payment term (days)
20
0
0
14
13
0
17
28
23
Positioning of LABORATOIRE NUGUES in its sector
Comparison with sector Fabrication de matériel médico-chirurgical et dentaire
Valuation estimate
Based on 57 transactions of similar company sales
(all years),
the value of LABORATOIRE NUGUES is estimated at
271 118 €
(range 77 137€ - 526 970€).
With an EBITDA of 113 410€, the sector multiple of 2.5x is applied.
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2025
57 tx
77k€271k€526k€
271 118 €Range: 77 137€ - 526 970€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
113 410 €×2.5x
Estimation287 989 €
56 600€ - 532 584€
Revenue Multiple30%
1 220 426 €×0.23x
Estimation276 793 €
128 640€ - 579 143€
Net Income Multiple20%
72 375 €×3.0x
Estimation220 431 €
51 225€ - 434 680€
How is this estimate calculated?
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fabrication de matériel médico-chirurgical et dentaire)
Compare LABORATOIRE NUGUES with other companies in the same sector:
Frequently asked questions about LABORATOIRE NUGUES
What is the revenue of LABORATOIRE NUGUES ?
The revenue of LABORATOIRE NUGUES in 2025 is 1.2 M€.
Is LABORATOIRE NUGUES profitable?
Yes, LABORATOIRE NUGUES generated a net profit of 72 k€ in 2025.
Where is the headquarters of LABORATOIRE NUGUES ?
The headquarters of LABORATOIRE NUGUES is located in LYON (69009), in the department Rhone.
Where to find the tax return of LABORATOIRE NUGUES ?
The tax return of LABORATOIRE NUGUES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LABORATOIRE NUGUES operate?
LABORATOIRE NUGUES operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart